MSC-VEGF treatment in 2xTg-AD APPswe/PS1dE9 mouse model favored neovascularisation and diminished senile plaques in the hippocampus, provided behavioral benefits, and reduced cognitive deficits [50]. This evidence concerns the gene VEGFA and Alzheimer disease.